Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

32 Kinase-Inhibitor Perturbed RNA sequencing of 11 cancer cell-lines

ABSTRACT: 32 Kinase-Inhibitor Perturbed RNA sequencing of 11 cancer cell-lines

PROVIDER: PRJNA773420 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

32 Kinase-Inhibitor Perturbed RNA sequencing of 11 cancer cell-lines

Project description:The goal of the CTD2 Pancancer Drug Activity DREAM Challenge is to foster the development and benchmarking of algorithms to predict targets of chemotherapeutic compounds from post-treatment transcriptional data. The drug perturbational profiles on 11 cell lines for 32 kinase inhibitors with well-established targets were provided to challenge participants, without revealing the identity of the drugs. These profiles were used to predict the drug-targets of the 32 anonymized drugs using publically available datasets for training.

2021-10-28 | GSE186341 | GEO

Tyrosine Kinase Inhibitor Cardiotoxicity

Project description:Tyrosine Kinase Inhibitor Cardiotoxicity

| PRJNA352077 | ENA

Panicum virgatum cultivar:SAP-32-11

Project description:Panicum virgatum exome capture - SAP-32-11

| PRJNA447820 | ENA

Escherichia coli strain:MG1655 IR-11-32

Project description:Escherichia coli MG1655 IR-11-32 population resequencing genome sequencing

| PRJNA363120 | ENA

Waddlia sp. IMSS/32/11/01/2012

Project description:Waddlia sp. IMSS/32/11/01/2012 Transcriptome or Gene expression

| PRJNA268154 | ENA

Transcriptomic changes from resulting from DARPP-32 modulation in breast cancer

Project description:DARPP-32 expression was reduced in oestrogen receptor positive luminal B breast cancer cells (T47D) using siRNA and control and DARPP-32 knockdown cells were subject to stimulation with estradiol17β (E2) or inhibition of protein kinase A (PKA) with PKA inhibitor fragment (6-22) amide prior to RNA sequencing. A bioinformatics pipeline of Trim Galore, Kallisto, DESeq2 and Qiagen Ingenuity Pathway Analysis was used for pathway analysis.

2023-10-30 | GSE204836 | GEO

BET inhibitor Pelabresib and AR inhibitor enzalutamide perturbed pathways in prostate cancer CRPC PDX LuCaP 35CR

Project description:BET inhibitor Pelabresib and AR inhibitor enzalutamide perturbed pathways in prostate cancer CRPC PDX LuCaP 35CR

| PRJNA1071482 | ENA

BET inhibitor Pelabresib and AR inhibitor enzalutamide perturbed pathways in prostate cancer CRPC PDX LuCaP 77CR

Project description:BET inhibitor Pelabresib and AR inhibitor enzalutamide perturbed pathways in prostate cancer CRPC PDX LuCaP 77CR

| PRJNA1067152 | ENA

BET inhibitor ABBV-075 perturbed pathways in prostate cancer organoid MSK-PCa17

Project description:BET inhibitor ABBV-075 perturbed pathways in prostate cancer organoid MSK-PCa17

| PRJNA1072115 | ENA

Expression profiling, U2OS, Aurora kinase and p38 inhibitor response

Project description:U-2 OS (human osteosarcoma cell line) were treated with ZM447439 (an aurora kinase inhibitor), SB202190 (a p38 inhibitor) or ZM447439+SB202190 and resulting changes in gene expression were profiled.

2017-07-01 | E-MTAB-1210 | biostudies-arrayexpress

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data